Journal
CELL
Volume 150, Issue 1, Pages 12-27Publisher
CELL PRESS
DOI: 10.1016/j.cell.2012.06.013
Keywords
-
Categories
Funding
- Wellcome-Beit Intermediate Clinical Fellowship
- Cancer Research UK (CRUK)
Ask authors/readers for more resources
The epigenetic regulation of DNA-templated processes has been intensely studied over the last 15 years. DNA methylation, histone modification, nucleosome remodeling, and RNA-mediated targeting regulate many biological processes that are fundamental to the genesis of cancer. Here, we present the basic principles behind these epigenetic pathways and highlight the evidence suggesting that their misregulation can culminate in cancer. This information, along with the promising clinical and preclinical results seen with epigenetic drugs against chromatin regulators, signifies that it is time to embrace the central role of epigenetics in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available